Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-17-019730
Filing Date
2017-01-26
Accepted
2017-01-26 16:09:00
Documents
16

Document Format Files

Seq Description Document Type Size
1 424B4 d320192d424b4.htm 424B4 1873231
2 GRAPHIC g320192g05u85.jpg GRAPHIC 121301
3 GRAPHIC g320192g28j55.jpg GRAPHIC 91905
4 GRAPHIC g320192g29m66.jpg GRAPHIC 38699
5 GRAPHIC g320192g34o44.jpg GRAPHIC 155424
6 GRAPHIC g320192g46g27.jpg GRAPHIC 115653
7 GRAPHIC g320192g50j92.jpg GRAPHIC 139558
8 GRAPHIC g320192g56g27.jpg GRAPHIC 45249
9 GRAPHIC g320192g56x38.jpg GRAPHIC 31642
10 GRAPHIC g320192g58l58.jpg GRAPHIC 60899
11 GRAPHIC g320192g64c21.jpg GRAPHIC 67506
12 GRAPHIC g320192g66f36.jpg GRAPHIC 63511
13 GRAPHIC g320192g68g50.jpg GRAPHIC 38270
14 GRAPHIC g320192g76f81.jpg GRAPHIC 68136
15 GRAPHIC g320192g77x14.jpg GRAPHIC 97288
16 GRAPHIC g320192g84l93.jpg GRAPHIC 114357
  Complete submission text file 0001193125-17-019730.txt   3583825
Mailing Address 10421 PACIFIC CENTER COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 10421 PACIFIC CENTER COURT, SUITE 200 SAN DIEGO CA 92121 858-362-6295
ANAPTYSBIO INC (Filer) CIK: 0001370053 (see all company filings)

EIN.: 203828755 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-206849 | Film No.: 17549788
SIC: 2834 Pharmaceutical Preparations